Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

Adding atezolizumab and bevacizumab to TACE can improve outcomes in previously untreated, unresectable HCC, data suggest.

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

MANILA, Philippines - Happy Hollow National High School of Baguio City, a public school that has initiated a program to teach ...

The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.

A new algorithm enables smartwatch fitness trackers to more accurately monitor energy expenditure of people with obesity ...

The Company notes that the Dogecoin Protocol remains under development, and there can be no assurance regarding its ...

To mark this special occasion, some of the country’s most respected health experts from various specialties come together to ...

This case is unique because it documents a rare occurrence of a Type IV stent fracture following percutaneous coronary ...

Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated ...

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

The estimated mean annual number of hypertension deaths from excessive alcohol use was higher in 2020–2021 than in 2016–2017, ...